A. K. Sanal Et Al. , "The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy," Expert Review of Anticancer Therapy , 2025
Sanal, A. K. Et Al. 2025. The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy. Expert Review of Anticancer Therapy .
Sanal, A. K., Turan, U., Yugruk, A., Taş, Z. A., Irkorucu, O., & TAŞKIN, Ö., (2025). The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy. Expert Review of Anticancer Therapy .
Sanal, Ali Et Al. "The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy," Expert Review of Anticancer Therapy , 2025
Sanal, Ali K. Et Al. "The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy." Expert Review of Anticancer Therapy , 2025
Sanal, A. K. Et Al. (2025) . "The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy." Expert Review of Anticancer Therapy .
@article{article, author={Ali Kaan Sanal Et Al. }, title={The discordance of biomarkers in primary tumour and synchronous axillary lymph node metastasis of the breast cancer, and its clinical significance in patients undergoing neoadjuvant therapy}, journal={Expert Review of Anticancer Therapy}, year=2025}